Smith Asset Management Group LP Has $1.71 Million Position in Petmed Express Inc (PETS)

Smith Asset Management Group LP trimmed its stake in shares of Petmed Express Inc (NASDAQ:PETS) by 21.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,829 shares of the company’s stock after selling 14,110 shares during the period. Smith Asset Management Group LP’s holdings in Petmed Express were worth $1,711,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of PETS. Public Employees Retirement Association of Colorado grew its holdings in Petmed Express by 265.5% during the third quarter. Public Employees Retirement Association of Colorado now owns 3,922 shares of the company’s stock worth $129,000 after acquiring an additional 2,849 shares during the period. Itau Unibanco Holding S.A. acquired a new stake in Petmed Express during the second quarter worth about $154,000. OppenheimerFunds Inc. acquired a new stake in Petmed Express during the second quarter worth about $205,000. Weatherly Asset Management L. P. acquired a new stake in Petmed Express during the second quarter worth about $205,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in Petmed Express during the second quarter worth about $211,000. 92.00% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently commented on the company. BidaskClub raised Petmed Express from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 18th. ValuEngine raised Petmed Express from a “strong sell” rating to a “sell” rating in a report on Monday, July 16th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $42.67.

Shares of PETS stock opened at $29.75 on Thursday. The company has a market cap of $616.50 million, a price-to-earnings ratio of 16.35 and a beta of 0.84. Petmed Express Inc has a 12-month low of $27.20 and a 12-month high of $57.80.

Petmed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, October 22nd. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The company had revenue of $71.40 million for the quarter, compared to the consensus estimate of $71.93 million. Petmed Express had a return on equity of 35.53% and a net margin of 14.88%. Petmed Express’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.43 earnings per share.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Monday, November 5th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, November 2nd. This represents a $1.08 dividend on an annualized basis and a yield of 3.63%. Petmed Express’s dividend payout ratio is currently 59.34%.

In other Petmed Express news, Director Robert C. Schweitzer sold 7,500 shares of the stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $37.00, for a total transaction of $277,500.00. Following the transaction, the director now owns 88,334 shares in the company, valued at $3,268,358. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 3.70% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Smith Asset Management Group LP Has $1.71 Million Position in Petmed Express Inc (PETS)” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://sportsperspectives.com/2018/11/08/smith-asset-management-group-lp-has-1-71-million-position-in-petmed-express-inc-pets.html.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Read More: Understanding Relative Strength Index

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply